Abstract:Beginning in the 1960s, animal and cell culture studies have demonstrated that transcranial photobiomodulation (t-PBM), which involves photons in the red and near-infrared spectrum, can penetrate the cerebral cortex and enhance the mitochondrial electron transport chain [1] (fNIRS similarly uses near infrared photons to image the brain, but at lower light intensities and exposure, resulting in minimal impact on brain function). Emerging human t-PBM data have demonstrated behavioral and clinical effects in multiple patient populations, along with effects on cerebral metabolism and hemodynamics, highlighting its potential therapeutic efficacy [1]. For example, small studies suggested that t-PBM delivered with both high (700 mW/cm 2 ) and low (36 mW/cm 2 ) irradiance [2] is effective in the treatment of major depressive disorder (MDD). However, since other studies with low t-PBM irradiance (55 mW/cm 2 ) did not replicate the positive results in MDD [3], it becomes critically important to further understand the irradiance dose-dependent neurobiological mechanisms of t-PBM, as we are attempting in our ongoing clinical trial [4]. t-PBM has an excellent safety profile [1,2,3], and it can be performed in multiple settings, including during magnetic resonance imaging (MRI) or other neuroimaging modalities, to quantify the impact on brain bioenergetics noninvasively and in real-time. However, work is still underway to determine the optimal parameters for clinical utility. Our team has recently demonstrated the effect of t-PBM, at medium irradiance (300 mW/cm 2 ), on regional intrinsic brain activity in 19 individuals with early Alzheimer's disease [AD] [5]. In this publication [5], we found that t-PBM altered the fractional amplitude of low-frequency fluctuations (fALFF) across all laser-irradiated brain cortical regions, which are limited to frontal regions due to skull density and hair interference. fALFF, assessed non-invasively during resting-state MRI, is a voxel-based measure of intrinsic brain activity measuring the regional brain metabolism: it is strongly correlated with cerebral glucose metabolism measured by [ 18 F]Fluorodeoxyglucose positron emission tomography. Similarly, other studies have reported increases in MRI BOLD signal (also in t-PBM-irradiated brain areas, at 300 mW/cm 2 irradiance) in healthy volunteers [6]. The increase in fALFF we detected in t-PBM-irradiated brain areas during stimulation [5], and the similar increases in MRI BOLD signal [6], suggest that t-PBM can increase intrinsic brain activity (and specifically cerebral metabolism) in real time; these effects continue briefly after t-PBM administration has ended.

Effects of transcranial photobiomodulation on peripheral biomarkers associated with oxidative stress and complex IV activity in the prefrontal cortex in rats subjected to chronic mild stress

Effect of Repetitive Transcranial Magnetic Stimulation on the Cognitive Impairment Induced by Sleep Deprivation: a Randomized Trial.

Transcranial photobiomodulation increases cognition and serum BDNF levels in adults over 50 years: A randomized, double-blind, placebo-controlled trial

Photobiomodulation therapy mitigates depressive-like behaviors by remodeling synaptic links and mitochondrial function

Dose-dependent effects of transcranial photobiomodulation on brain temperature in patients with major depressive disorder: a spectroscopy study

Primary stimulus generalization.

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Brain-gut photobiomodulation restores cognitive alterations in chronically stressed mice through the regulation of Sirt1 and neuroinflammation

Inflammation in obsessive–compulsive disorder: A literature review and hypothesis‐based potential of transcranial photobiomodulation

Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy

Effects of a new hemostatic agent on blood coagulation.

Brain-derived neurotrophic factor modulation in response to oxidative stress and corticosterone: Role of scopolamine and mirtazapine

Brain photobiomodulation therapy on neurological and psychological diseases

Transcranial photobiomodulation in children aged 2–6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology

Pulsed Transcranial Photobiomodulation Generates Distinct Beneficial Neurocognitive Effects Compared with Continuous Wave Transcranial Light

Efficacy of transcranial photobiomodulation in the treatment for major depressive disorder: A TMS‐EEG and pilot study

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges

Altered blood parameters in "major depression" patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study

[1997 FIVNAT general balance].

Effects of intermittent theta-burst transcranial magnetic stimulation on cognition and hippocampal volumes in bipolar depression

Effects of Repetitive Transcranial Magnetic Stimulation on Cognitive Function in Patients with Stress-Related Depression: A Randomized Double-Blind Fmri and 1H-MRS Study.